Leidos (LDOS) Laps the Stock Market: Here's Why

Leidos (LDOS) closed at $184.90, up 1.39% and outperforming the S&P 500, though its monthly gain of 0.55% lagged the broader tech sector. Analysts project a 10.58% year-over-year decline in upcoming quarterly EPS to $2.62 on $4.28 billion in revenue, while full-year estimates forecast a 9.89% EPS increase to $11.22 and 2.95% revenue growth to $17.15 billion. The stock holds a Zacks Rank of #2 (Buy) and trades with a Forward P/E of 16.25, consistent with its industry average, and a PEG ratio of 1.74, below the industry's 2.0.

Analysis

Leidos (LDOS) exhibited short-term strength, outperforming the S&P 500 with a 1.39% daily gain, yet its monthly performance of +0.55% significantly trails both the S&P 500's 2.72% gain and its sector's 7.68% advance. The immediate focus for investors is the upcoming earnings release, which carries a mixed outlook. Analysts anticipate a 10.58% year-over-year decline in quarterly EPS to $2.62, even as revenue is projected to grow 2.06% to $4.28 billion, suggesting potential margin compression. However, the full-year forecast is more constructive, with consensus estimates pointing to a 9.89% increase in EPS to $11.22 and a 2.95% rise in revenue. This longer-term optimism is reinforced by a slight 0.26% upward revision in the consensus EPS estimate over the past month and a Zacks Rank of #2 (Buy). From a valuation perspective, LDOS trades at a Forward P/E of 16.25, directly in line with its industry average, while its PEG ratio of 1.74 is below the industry's 2.0, indicating its price may be attractive relative to its growth prospects. The company also operates within the Computers - IT Services industry, which ranks in the top 42% of industries, providing a generally favorable market backdrop.

Key Decisions for Investors

• Investors should be prepared for potential near-term volatility surrounding the upcoming earnings report, given the consensus forecast for a 10.58% year-over-year decline in earnings per share.
• Despite the short-term earnings headwind, the positive full-year growth outlook (+9.89% EPS) and the stock's #2 (Buy) Zacks Rank may warrant holding or accumulating for those with a longer-term investment horizon.
• The stock's valuation appears reasonable, with a Forward P/E in line with its peers and a PEG ratio of 1.74 below the industry average, suggesting it may be attractively priced relative to its projected growth.